Skip to main content

Mesulergine









Mesulergine


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search





















































Mesulergine
Mesulergine.svg
Identifiers
CAS Number

  • 64795-35-3 ☒N

PubChem CID
  • 68848
IUPHAR/BPS

  • 206

  • [3H]mesulergine: 232

ChemSpider

  • 62081 ☑Y
UNII
  • SML95FK06I
ChEBI

  • CHEBI:73378 ☒N
ChEMBL

  • ChEMBL462903 ☒N
Chemical and physical data
Formula
C18H26N4O2S
Molar mass 362.49 g/mol
3D model (JSmol)
  • Interactive image

.mw-parser-output .nobold{font-weight:normal}
 ☒N☑Y (what is this?)
  (verify)

Mesulergine is a psychoactive drug of the ergoline chemical class that acts on serotonin and dopamine receptors.[1][2]


The compound had entered clinical trials for the treatment of Parkinson's disease; however, further development was halted due to adverse histological abnormalities in rats.[3]



References[edit]





  1. ^ Closse A (May 1983). "[3H]Mesulergine, a selective ligand for serotonin-2 receptors". Life Sci. 32 (21): 2485–95. doi:10.1016/0024-3205(83)90375-2. PMID 6855451..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  2. ^ Markstein R (November 1983). "Mesulergine and its 1,20-N,N-bidemethylated metabolite interact directly with D1- and D2-receptors". Eur. J. Pharmacol. 95 (1–2): 101–7. doi:10.1016/0014-2999(83)90272-8. PMID 6230246.


  3. ^ Dupont E, Mikkelsen B, Jakobsen J (April 1986). "Mesulergine in early Parkinson's disease: a double blind controlled trial". J. Neurol. Neurosurg. Psychiatry. 49 (4): 390–5. doi:10.1136/jnnp.49.4.390. PMC 1028763. PMID 3517235.
















Retrieved from "https://en.wikipedia.org/w/index.php?title=Mesulergine&oldid=869996839"





Navigation menu

























(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.876","walltime":"1.069","ppvisitednodes":{"value":4791,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":352692,"limit":2097152},"templateargumentsize":{"value":4911,"limit":2097152},"expansiondepth":{"value":16,"limit":40},"expensivefunctioncount":{"value":3,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":9441,"limit":5000000},"entityaccesscount":{"value":3,"limit":400},"timingprofile":["100.00% 647.229 1 -total"," 63.86% 413.348 1 Template:Drugbox"," 47.41% 306.871 1 Template:Infobox"," 20.77% 134.407 1 Template:Reflist"," 19.67% 127.300 21 Template:Navbox"," 18.68% 120.918 3 Template:Cite_journal"," 15.86% 102.683 16 Template:Unbulleted_list"," 7.74% 50.083 1 Template:Serotonergics"," 7.11% 45.990 1 Template:Infobox_drug/chemical_formula"," 3.21% 20.782 1 Template:Dopaminergics"]},"scribunto":{"limitreport-timeusage":{"value":"0.239","limit":"10.000"},"limitreport-memusage":{"value":4409143,"limit":52428800}},"cachereport":{"origin":"mw1329","timestamp":"20181215044806","ttl":1900800,"transientcontent":false}}});});{"@context":"https://schema.org","@type":"Article","name":"Mesulergine","url":"https://en.wikipedia.org/wiki/Mesulergine","sameAs":"http://www.wikidata.org/entity/Q6822173","mainEntity":"http://www.wikidata.org/entity/Q6822173","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https://www.wikimedia.org/static/images/wmf-hor-googpub.png"}},"datePublished":"2007-09-22T17:26:27Z","dateModified":"2018-11-21T18:57:27Z","image":"https://upload.wikimedia.org/wikipedia/commons/a/a8/Mesulergine.svg","headline":"chemical compound"}(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgBackendResponseTime":142,"wgHostname":"mw1262"});});

Popular posts from this blog

Full-time equivalent

Bicuculline

さくらももこ